ORIGINAL ARTICLE
Effect of serum creatine kinase-MBmass on the early and hierarchical diagnosis of related artery reperfusion in acute myocardial infarction
1 Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health; Department of Cardiology QiLu Hospital Shandong University, Jinan 250012, China
2 Department of Cardiology, Qianfoshan Hospital of Shandong Province, Jinan 250014, China
Correspondence to:
Correspondence to:
Professor Wei Zhang
Department of Cardiology, Shandong University QiLu Hospital, 250012, 107# West Wenhua Road, Jinan, China; professor-zhangwei{at}163.com
Aim: To evaluate creatine kinase-MBmass (CK-MBmass) for the early diagnosis of infarct-related artery (IRA) patency after thrombolysis and the hierarchical diagnosis of related artery reperfusion (RAR).
Patients and methods: CK-MBmass and creatine kinase-MBactivity (CK-MBactivity) were measured kinetically in 48 patients treated with thrombolysis and 96 patients treated with routine drugs.
Results: In the continuous-RAR (CRAR) group, the peak values of CK-MBmass and CK-MBactivity appeared at 
12 h, the peak durations were maintained for 8 h before decreasing to normal at 42 h, which occurred more quickly than those values in the non-RAR (NRAR) group. In the temporary-RAR (TRAR) group, the peak values appeared at 12 h, but no significant differences were found between the TRAR and NRAR groups in the time that the peak durations lasted before decreasing to normal values. In the reobliteration group after RAR, the peak values appeared at 12 h, and the peak durations were maintained for 8 h. After returning to the normal, a second peak appeared, and the time required for the values to return to normal was prolonged significantly.
Conclusions: CK-MBmass could be used as an indicator of RAR after thrombolysis; and the kinetic changes of serum CK-MBmass could be used for the hierarchical diagnosis of RAR in acute myocardial infarction.
Abbreviations: AMI, acute myocardial infarction; CK, creatine kinase; CK-MB, creatine kinase-MB; CK-MBactivity, creatine kinase-MBactivity; CK-MBmass, creatine kinase-MBmass; CRAR, continuous-RAR; cTnI, cardiac troponin I; cTnT, cardiac troponin T; ECG, electrocardiogram; IRA, infarct-related artery; MEIA, microparticle enzyme immunoassay; NRAR, non-RAR; PTCA, percutaneous transluminal coronary angioplasty; RAR, related artery reperfusion; TIMI, Thrombolysis in Myocardial Infarction; t-PA, tissue plasminogen activator; TRAR, temporary-RAR
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
